Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study
Alessandro Marco Minisini, Fabio Puglisi(University of Udine), Matteo Balestrieri(University of Udine), Rachele Fantinel(University of Udine), Claudia Andreetta(Ospedale Santa Maria della Misericordia di Udine), Paola Ermacora(Presidio Ospedaliero), Andrea Piga, Sara De Faccio(University of Udine)
Cited by 39
Related Papers
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
|Journal of Clinical Oncology|2010|887
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282